In vitro activities of the lipopeptides palmitoyl (Pal)-Lys-Lys-NH 2 and Pal-Lys-Lys alone and in combination with antimicrobial agents against multiresistant gram-positive cocci

Antimicrobial Agents and Chemotherapy

Volumn 51, Issue 1, 2007, Pages 354-358

  Kamysz, Wojciech ^a   Silvestri, Carmela ^b   Cirioni, Oscar ^b   Giacometti, Andrea ^b,d   Licci, Alberto ^b   Della Vittoria, Agnese ^b   Okroj, Marcin ^c   Scalise, Giorgio ^b  

^a MEDICAL UNIVERSITY OF GDANSK   (Poland)

^b UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^c LUND UNIVERSITY   (Sweden)

^d Ospedale Regionale Torrette   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADJUVANT; ANTIBIOTIC AGENT; LIPOPEPTIDE; PALMITOYLLYSLLYSINE; PALMITOYLLYSYLLYSINE AMIDE; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIUM ISOLATE; CONTROLLED STUDY; DRUG DESIGN; DRUG POTENTIATION; DRUG STRUCTURE; ENTEROCOCCUS FAECALIS; ERYTHROCYTE; GRAM POSITIVE BACTERIUM; HEMOLYSIS; HUMAN; HUMAN CELL; IN VITRO STUDY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; NONHUMAN; PRIORITY JOURNAL; RHODOCOCCUS EQUI; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PYOGENES;

ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; DRUG SYNERGISM; GRAM-POSITIVE COCCI; HEMOLYSIS; HUMANS; LIPOPROTEINS; MICROBIAL SENSITIVITY TESTS; MOLECULAR STRUCTURE; PEPTIDES;

EID: 33845984047     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.00344-06     Document Type: Article

References (19)

1. Avrahami, D., and Y. Shai. 2002. Conjugation of a magainin analogue with lipophilic acids controls hydrophobicity, solution assembly, and cell selectivity. Biochemistry 41:2254-2263.
2. Avrahami, D., and Y. Shai. 2003. Bestowing antifungal and antibacterial activities by lipophilic acid conjugation to D,L-amino acid-containing antimicrobial peptides: a plausible mode of action. Biochemistry 42:14946-14956.
3. Avrahami, D., and Y. Shai. 2004. A new group of antifungal and antibacterial lipopeptides derived from non-membrane active peptides conjugated to palmitic acid. J. Biol. Chem. 279:12277-12285.
4. Cannon, M. 1987. A family of wound healers. Nature 328:478.
5. Cormican, M. G., and R. N. Jones. 1996. Emerging resistance to antimicrobial agents in gram-positive bacteria. Enterococci, staphylococci and nonpneumococcal streptococci. Drugs 51:S6-S12.
6. Eliopoulos, G. M., and R. C. Moellering, Jr. 1996. Antimicrobial combinations, p. 330-393. In V. Lorian (ed.), Antibiotics in laboratory medicine. The Williams & Wilkins Co., Baltimore, MD.
7. Epand, R. M., and H. J. Vogel. 1999. Diversity of antimicrobial peptides and their mechanisms of action. Biochim. Biophys. Acta 1462:11-28.
8. Fields, G. B., and R. L. Noble. 1990. Solid phase peptide synthesis utilizing 9-fluorenylmethoxycarbonyl amino acids. Int. J. Pept. Protein Res. 35:161-214.
9. Gonzalez, A., T. Bischoff, S. Tallent, G. Sheke, B. Ostrowski, M. B. Edmond, and R. P. Wenzel. 2003. Antibiotic resistance in the community. J. Hosp. Infect. 55:156-157.
10. Hancock, R. E. W. 2001. Cationic peptides: effectors in innate immunity and novel antimicrobials. Lancet Infect. Dis. 1:156-164.
11. Hancock, R. E. W., and D. S. Chapple. 1999. Peptide antibiotics. Antimicrob. Agents Chemother. 43:1317-1323.
12. Kamysz, W., B. Kochańska, A. Kȩdzia, J. Ochocińska, Z. Maćkiewicz, and G. Kupryszewski. 2002. Statherin SV2 and its analogue. Synthesis and evaluation of antimicrobial activity. Pol. J. Chem. 76:801-806.
13. Makovitzki, A., and Y. Shai. 2005. pH-dependent antifungal lipopeptides and their plausible mode of action. Biochemistry 44:9775-9784.
14. Malina, A., and Y. Shai. 2005. Conjugation of fatty acids with different lengths modulates the antibacterial and antifungal activity of a cationic biologically inactive peptide. Biochem. J. 390:695-702.
15. National Committee for Clinical Laboratory Standards. 2003. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically: approved standard M7-A6. National Committee for Clinical Laboratory Standards, Wayne, PA.
16. Putsep, K., C. I. Branden, H. G. Boman, and S. Normark. 1999. Antibacterial peptide from H. pylori. Nature 398:671-672.
17. Raad, I., A., Alrahwan, and K. Rolston. 1998. Staphylococcus epidermidis: emerging resistance and need for alternative agents. Clin. Infect. Dis. 26: 1182-1187.
18. Steiner, H., D. Hultmark, A. Engstrom, H. Bennich, and H. G. Boman. 1981. Sequence and specificity of two antibacterial proteins involved in insect immunity. Nature 292:246-248.
19. Woodford, N. 2005. Biological counterstrike: antibiotic resistance mechanism of gram-positive cocci. Clin. Microbiol. Infect. 11:S2-S21.